The ALS Therapy Development Institute (ALS TDI) has developed a tool that maps ALS clinical trials globally, using technology from Esri. Dubbed ALS Trial Navigator, the tool is designed to streamline ...
SAN FRANCISCO, June 02, 2026--(BUSINESS WIRE)--Lou Gehrig Day — EverythingALS, a nonprofit dedicated to accelerating research, technology, and patient access for amyotrophic lateral sclerosis (ALS), ...
KANSAS CITY, Mo. — A local man is thankful for the groundbreaking research happening in a lab at the Stowers Institute in Kansas City, Missouri. KSHB 41 News Reporter Megan Abundis spent her day ...
The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...
NEW YORK--(BUSINESS WIRE)--Medidata, a Dassault Systèmes company, and the global leader in creating end-to-end solutions supporting the entire clinical trial process, announced the launch of a ...
CAMBRIDGE, Mass. and AMSTERDAM, May 7, 2012 /PRNewswire-USNewswire/ -- The ALS Therapy Development Institute (ALS TDI) announced today that it has entered into a partnership with Regenesance to ...
WASHINGTON, DC (April 30, 2024)—Tambourine Philanthropies (Tambourine), in partnership with the Milken Institute Science Philanthropy Accelerator for Research and Collaboration (SPARC), is pleased to ...
Donated blood and tissue samples to be used to identify molecular signature of motor neuron disease CAMBRIDGE, Mass., Aug. 19 /PRNewswire-USNewswire/ -- ALS Therapy Development Institute (ALS TDI) ...
Broken String Biosciences, a gene therapy company based in Cambridge, U.K., has announced a new research collaboration with the Francis Crick Institute in London. The Crick Institute’s researchers ...
Robert Sepucha Jr. is senior vice president, policy and business development for Fresenius Medical Care North America. Prior to joining Fresenius, Sepucha served as general counsel for the ...
This ALS-focused research will be supported by EverythingALS and Vision 2030’s $1M initial investment in the newly launched Allen Institute’s Brain Health Accelerator. The Allen Institute has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results